Early consumption of peanuts in infancy is associated with a low prevalence of peanut allergy

George Du Toit1, Yitzhak Katz, Peter Sasieni

  • 1King's College London, MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, Division of Asthma, Allergy and Lung Biology, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Insights

Peanut allergy (PA) is 10 times more common in UK Jewish children than in Israeli Jewish children. Early introduction of peanuts in infancy may prevent PA, contrary to current avoidance guidelines.

Area of Science:

  • Allergy and Immunology
  • Pediatrics
  • Epidemiology

Background:

  • Peanut allergy (PA) prevalence is rising globally, despite avoidance guidelines in infancy.
  • Current guidelines in the UK, Australia, and North America recommend peanut avoidance in early life.

Purpose of the Study:

  • To determine and compare the prevalence of PA in UK and Israeli Jewish children.
  • To investigate the association between PA and infant/maternal peanut consumption patterns.

Main Methods:

  • Clinically validated questionnaires assessed PA prevalence in 5171 UK and 5615 Israeli schoolchildren.
  • A second questionnaire evaluated peanut consumption and weaning practices in 77 UK and 99 Israeli infants.

Main Results:

  • PA prevalence was significantly higher in the UK (1.85%) compared to Israel (0.17%).
  • UK children had a 9.8-fold increased risk of PA compared to Israeli children, even after accounting for atopy.
  • Israeli infants consumed significantly more peanut protein earlier and more frequently than UK infants, who avoided peanuts.

Conclusions:

  • UK Jewish children exhibit a 10-fold higher prevalence of PA than their Israeli counterparts.
  • This disparity is not explained by atopy, socioeconomic factors, genetics, or allergenicity.
  • Findings suggest early infant peanut introduction, as practiced in Israel, may be a strategy to prevent PA development.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Preparedness and Phobias01:09

Preparedness and Phobias

Human fear responses to certain stimuli, such as darkness, heights, deep water, and blood, can often arise despite the absence of direct negative experiences. This phenomenon is rooted in evolutionary psychology, which posits that humans have developed a predisposition to fear stimuli that historically posed significant survival threats. This predisposition, known as preparedness, suggests that early humans who developed a fear of potentially dangerous entities, such as venomous snakes and...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...